Semi-Annual Consolidated Statement Of Changes In Equity

Daito Pharmaceutical Co., Ltd. - Filing #7542348

Concept 2023-06-01 to
2023-08-31
As at
2023-08-31
As at
2023-05-31
2022-06-01 to
2022-08-31
Semi-annual consolidated statement of changes in equity
Statement of changes in equity
Net assets
51,332,000,000 JPY
50,971,000,000 JPY
Changes during period
Profit (loss) attributable to owners of parent
683,000,000 JPY
946,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.